Related Experiment Video
Updated: Jul 15, 2026

Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder
Published on: November 25, 2025
Reevaluation of initial therapy. When is the appropriate time?
Stuart L Segelnick1, Mea A Weinberg
1Department of Periodontology and Implant Dentistry, New York University College of Dentistry, USA.
Reevaluating periodontal therapy timing is crucial for effective patient care. Determining the optimal reevaluation period prevents both overtreatment and disease progression, ensuring evidence-based dental medicine.
Area of Science:
- Periodontology
- Evidence-Based Dentistry
Background:
- The timing for periodontal reevaluation after initial therapy is ambiguous and lacks consensus in current literature.
- Existing studies present varied or absent timeframes for reevaluation, creating a dichotomy with evidence-based practices.
Purpose of the Study:
- To define periodontal reevaluation and establish an optimal time interval for its performance post-initial therapy.
- To address concerns regarding the risks of premature or delayed reevaluation, such as overtreatment or disease progression.
Main Methods:
- Review of classic and current scientific literature on periodontal therapy and reevaluation.
- Analysis of expert opinions from periodontists regarding reevaluation timing.
Main Results:
- Literature review reveals inconsistent or absent guidelines for periodontal reevaluation timing.
- The optimal reevaluation period remains undefined, leading to potential clinical challenges.
Conclusions:
- A standardized, evidence-based timeframe for periodontal reevaluation is needed.
- Establishing this interval is critical to avoid patient overtreatment and prevent disease progression.
Related Concept Videos
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Drug Therapy
Antianxiety Medications
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Endocarditis III: Medical Management